| 1 | Ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, TGFB2, TNXB | 10.40 |
| 2 | Multiple epiphyseal dysplasia due to collagen 9 anomaly | Enrichment | COL9A1, COL9A2, COL9A3 | 10.25 |
| 3 | Autosomal recessive stickler syndrome | Enrichment | COL9A1, COL9A2, COL9A3 | 9.62 |
| 4 | Stickler syndrome | Enrichment | COL2A1, COL9A1, COL9A2, COL9A3, VCAN | 8.93 |
| 5 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | BGN, COL1A1, COL3A1, COL5A1, COL5A2, TGFB2, TGFB3 | 8.37 |
| 6 | Ehlers-danlos syndrome, classic type, 1 | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2 | 7.87 |
| 7 | Classic ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2 | 7.87 |
| 8 | Nephrotic syndrome | Enrichment | COL4A3, COL4A4, COL4A5, FN1, LAMA5, LAMB2 | 6.88 |
| 9 | Collagen vi-related dystrophies | Enrichment | COL6A1, COL6A2, COL6A3 | 6.77 |
| 10 | Intermediate collagen vi-related muscular dystrophy | Enrichment | COL6A1, COL6A2, COL6A3 | 6.77 |
| 11 | Digenic alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 6.77 |
| 12 | Dysfibrinogenemia, congenital | Enrichment | FGA, FGB, FGG | 6.64 |
| 13 | Familial dysfibrinogenemia | Enrichment | FGA, FGB, FGG | 6.64 |
| 14 | Familial hypofibrinogenemia | Enrichment | FGA, FGB, FGG | 6.64 |
| 15 | Bethlem muscular dystrophy | Enrichment | COL6A1, COL6A2, COL6A3 | 6.17 |
| 16 | Afibrinogenemia, congenital | Enrichment | FGA, FGB, FGG | 6.04 |
| 17 | Kidney disease | Enrichment | COL4A3, COL4A4, COL4A5, LAMB2 | 5.93 |
| 18 | Connective tissue disease | Enrichment | COL2A1, COL5A1, COL9A1, COL9A3, FBN1 | 5.85 |
| 19 | Alport syndrome 3a, autosomal dominant | Enrichment | COL4A3, COL4A4, COL4A5 | 5.78 |
| 20 | Ullrich congenital muscular dystrophy 1a | Enrichment | COL6A1, COL6A2, COL6A3 | 5.78 |
| 21 | Autosomal dominant alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 5.78 |
| 22 | Alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 5.78 |
| 23 | Keratoconus | Enrichment | COL1A1, COL4A1, COL5A2 | 5.48 |
| 24 | Fetomaternal alloimmune thrombocytopenia 1 | Enrichment | ITGA2, ITGA2B, ITGB3 | 5.48 |
| 25 | Intervertebral disc disease | Enrichment | COL9A2, COL9A3 | 5.47 |
| 26 | Bethlem myopathy 1a | Enrichment | COL6A1, COL6A2, COL6A3 | 5.24 |
| 27 | Epiphyseal dysplasia, multiple, 1 | Enrichment | COL1A1, COMP | 4.51 |
| 28 | Ehlers-danlos syndrome, hypermobility type | Enrichment | COL3A1, TNXB | 4.51 |
| 29 | Spondyloepimetaphyseal dysplasia, strudwick type | Enrichment | COL2A1, FN1 | 4.51 |
| 30 | Spondylometaphyseal dysplasia, corner fracture type | Enrichment | COL2A1, FN1 | 4.51 |
| 31 | Ehlers-danlos syndrome, arthrochalasia type, 2 | Enrichment | COL1A1, COL1A2 | 4.51 |
| 32 | Loeys-dietz syndrome 4 | Enrichment | TGFB2, TGFB3 | 4.51 |
| 33 | Ehlers-danlos/osteogenesis imperfecta syndrome | Enrichment | COL1A1, COL1A2 | 4.51 |
| 34 | Dentinogenesis imperfecta | Enrichment | COL1A2, DSPP | 4.51 |
| 35 | X-linked diffuse leiomyomatosis-alport syndrome | Enrichment | COL4A5, COL4A6 | 4.51 |
| 36 | Postsynaptic congenital myasthenic syndromes | Enrichment | AGRN, LRP4, MUSK | 4.45 |
| 37 | Aortic dissection | Enrichment | COL3A1, FBN1 | 4.42 |
| 38 | Osteogenesis imperfecta, type iv | Enrichment | COL1A1, COL1A2, SPARC | 4.33 |
| 39 | Hematuria, benign familial, 1 | Enrichment | COL4A3, COL4A4 | 4.03 |
| 40 | Bleeding disorder, platelet-type, 16 | Enrichment | ITGA2B, ITGB3 | 4.03 |
| 41 | Ehlers-danlos syndrome, classic type, 2 | Enrichment | COL5A1, COL5A2 | 4.03 |
| 42 | High bone mass osteogenesis imperfecta | Enrichment | COL1A1, COL1A2 | 4.03 |
| 43 | Multiple epiphyseal dysplasia | Enrichment | COL2A1, COMP | 4.03 |
| 44 | Myopia | Enrichment | COL2A1, COL4A4, FBN1 | 4.01 |
| 45 | Myopathy | Enrichment | COL6A1, COL6A2, COL6A3, FBN1 | 3.98 |
| 46 | Mccune-albright syndrome | Enrichment | COL2A1, FBN1 | 3.95 |
| 47 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | COL1A1, COL1A2 | 3.73 |
| 48 | Brain small vessel disease 1 with or without ocular anomalies | Enrichment | COL4A1, COL4A2 | 3.73 |
| 49 | Alport syndrome 2, autosomal recessive | Enrichment | COL4A3, COL4A4 | 3.73 |
| 50 | Autosomal recessive alport syndrome | Enrichment | COL4A3, COL4A4 | 3.73 |
| 51 | Osteogenesis imperfecta with normal sclerae, dominant form | Enrichment | COL1A1, COL1A2 | 3.73 |
| 52 | Thrombocytopenia | Enrichment | FGG, ITGA2B, ITGB3, VWF | 3.66 |
| 53 | Retinal detachment | Enrichment | COL2A1, COL9A3 | 3.51 |
| 54 | Familial porencephaly | Enrichment | COL4A1, COL4A2 | 3.51 |
| 55 | Epidermolysis bullosa | Enrichment | COL7A1, ITGA6 | 3.43 |
| 56 | Pseudoachondroplasia | Enrichment | COMP | 3.35 |
| 57 | Epiphyseal dysplasia, multiple, 6 | Enrichment | COL9A1 | 3.35 |
| 58 | Carpal tunnel syndrome 2 | Enrichment | COMP | 3.35 |
| 59 | Epiphyseal dysplasia, multiple, 2 | Enrichment | COL9A2 | 3.35 |
| 60 | Epiphyseal dysplasia, multiple, 3 | Enrichment | COL9A3 | 3.35 |
| 61 | Stickler syndrome, type iv | Enrichment | COL9A1 | 3.35 |
| 62 | Stickler syndrome, type v | Enrichment | COL9A2 | 3.35 |
| 63 | Retinal lattice degeneration | Enrichment | COL9A3 | 3.35 |
| 64 | Osteogenesis imperfecta, type i | Enrichment | COL1A1, COL1A2 | 3.34 |
| 65 | Hemorrhage, intracerebral | Enrichment | COL4A1, COL4A2 | 3.34 |
| 66 | Inguinal hernia | Enrichment | COL5A1, FBN1 | 3.25 |
| 67 | Osteogenesis imperfecta, type ii | Enrichment | COL1A1, COL1A2 | 3.19 |
| 68 | Glanzmann thrombasthenia 1 | Enrichment | ITGA2B, ITGB3 | 3.19 |
| 69 | Epiphyseal dysplasia, multiple, 5 | Enrichment | MATN3 | 3.05 |
| 70 | Spondyloepimetaphyseal dysplasia, borochowitz-cormier-daire type | Enrichment | MATN3 | 3.05 |
| 71 | Stickler syndrome, type vi | Enrichment | COL9A3 | 3.05 |
| 72 | Spastic paraplegia 4, autosomal dominant | Enrichment | COL3A1, FGG | 2.98 |
| 73 | Orthostatic intolerance | Enrichment | COL5A1, FBN1 | 2.98 |
| 74 | Loeys-dietz syndrome | Enrichment | TGFB2, TGFB3 | 2.96 |
| 75 | Familial thoracic aortic aneurysm and dissection | Enrichment | COL3A1, FBN1 | 2.88 |
| 76 | Marfan syndrome | Enrichment | COL2A1, TGFB2 | 2.87 |
| 77 | Autosomal dominant macrothrombocytopenia | Enrichment | ITGA2B, ITGB3 | 2.87 |
| 78 | Primary bone dysplasia | Enrichment | COL1A1, COL1A2 | 2.87 |
| 79 | Osteochondrodysplasia | Enrichment | COL1A1, COL1A2 | 2.78 |
| 80 | Presynaptic congenital myasthenic syndromes | Enrichment | AGRN, LAMA5 | 2.78 |
| 81 | Chronic kidney disease | Enrichment | COL4A4, COL4A5 | 2.63 |
| 82 | Multiple sclerosis | Enrichment | LAMA5, LAMB1 | 2.57 |
| 83 | Osteoporosis | Enrichment | COL1A1, COL1A2 | 2.57 |
| 84 | Walker-warburg syndrome | Enrichment | COL4A1, DAG1 | 2.57 |
| 85 | Osteogenesis imperfecta, type iii | Enrichment | COL1A1, COL1A2 | 2.51 |
| 86 | Aortic aneurysm, familial thoracic 1 | Enrichment | COL3A1, FBN1 | 2.48 |
| 87 | Cataract | Enrichment | COL18A1, COL5A1 | 2.48 |
| 88 | Isolated macular dystrophy | Enrichment | COL4A5, ITGA4 | 2.48 |
| 89 | Creatine phosphokinase, elevated serum | Enrichment | DAG1, LAMA2 | 2.45 |
| 90 | Hypertension | Enrichment | COL4A4, COL4A5 | 2.45 |
| 91 | Isolated elevated serum creatine phosphokinase levels | Enrichment | DAG1, LAMA2 | 2.45 |
| 92 | Beckwith-wiedemann syndrome | Enrichment | COL6A1, COL7A1 | 2.26 |
| 93 | Focal segmental glomerulosclerosis | Enrichment | COL4A4, COL4A5 | 2.26 |
| 94 | Stickler syndrome, type i | Enrichment | COL2A1 | 2.25 |
| 95 | Short stature and advanced bone age with or without early-onset osteoarthritis and/or osteochondritis dissecans | Enrichment | ACAN | 2.25 |
| 96 | Epiphyseal dysplasia, multiple, with myopia and conductive deafness | Enrichment | COL2A1 | 2.25 |
| 97 | Ehlers-danlos syndrome, cardiac valvular type | Enrichment | COL1A2 | 2.25 |
| 98 | Hypophosphatemic rickets, autosomal recessive, 1 | Enrichment | DMP1 | 2.25 |
| 99 | Spondylometaphyseal dysplasia, algerian type | Enrichment | COL2A1 | 2.25 |
| 100 | Alport syndrome 1, x-linked | Enrichment | COL4A5 | 2.25 |
| 101 | Osteoarthritis with mild chondrodysplasia | Enrichment | COL2A1 | 2.25 |
| 102 | Avascular necrosis of femoral head, primary, 1 | Enrichment | COL2A1 | 2.25 |
| 103 | Czech dysplasia | Enrichment | COL2A1 | 2.25 |
| 104 | Kniest dysplasia | Enrichment | COL2A1 | 2.25 |
| 105 | Cardiomyopathy, dilated, 1jj | Enrichment | LAMA4 | 2.25 |
| 106 | Dentinogenesis imperfecta 1 | Enrichment | DSPP | 2.25 |
| 107 | Dentinogenesis imperfecta, shields type iii | Enrichment | DSPP | 2.25 |
| 108 | Platyspondylic lethal skeletal dysplasia, torrance type | Enrichment | COL2A1 | 2.25 |
| 109 | Dentin dysplasia, type ii | Enrichment | DSPP | 2.25 |
| 110 | Muscular dystrophy-dystroglycanopathy , type a, 9 | Enrichment | DAG1 | 2.25 |
| 111 | Deafness, autosomal dominant 39, with dentinogenesis imperfecta 1 | Enrichment | DSPP | 2.25 |
| 112 | Spondyloepiphyseal dysplasia, stanescu type | Enrichment | COL2A1 | 2.25 |
| 113 | Lissencephaly 5 | Enrichment | LAMB1 | 2.25 |
| 114 | Deafness, autosomal dominant 56 | Enrichment | TNC | 2.25 |
| 115 | Acrogeria, gottron type | Enrichment | COL3A1 | 2.25 |
| 116 | Achondrogenesis, type ii | Enrichment | COL2A1 | 2.25 |
| 117 | Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | Enrichment | TNR | 2.25 |
| 118 | Nephrotic syndrome, type 26 | Enrichment | LAMA5 | 2.25 |
| 119 | Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency | Enrichment | MUSK | 2.25 |
| 120 | Deafness, x-linked 6 | Enrichment | COL4A6 | 2.25 |
| 121 | Ullrich congenital muscular dystrophy 1b | Enrichment | COL6A2 | 2.25 |
| 122 | Fetomaternal alloimmune thrombocytopenia 2 | Enrichment | ITGA2B | 2.25 |
| 123 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 2 | Enrichment | COL1A2 | 2.25 |
| 124 | Meester-loeys syndrome | Enrichment | BGN | 2.25 |
| 125 | Spondyloperipheral dysplasia | Enrichment | COL2A1 | 2.25 |
| 126 | Myosclerosis, autosomal recessive | Enrichment | COL6A2 | 2.25 |
| 127 | Porencephaly | Enrichment | COL4A1 | 2.25 |
| 128 | Ullrich congenital muscular dystrophy 1c | Enrichment | COL6A3 | 2.25 |
| 129 | Plasminogen activator inhibitor-1 deficiency | Enrichment | SERPINE1 | 2.25 |
| 130 | Spondyloepimetaphyseal dysplasia, aggrecan type | Enrichment | ACAN | 2.25 |
| 131 | Camurati-engelmann disease 2 | Enrichment | TGFB2 | 2.25 |
| 132 | Spondyloepiphyseal dysplasia, kimberley type | Enrichment | ACAN | 2.25 |
| 133 | Cerebral amyloid angiopathy, app-related | Enrichment | APP | 2.25 |
| 134 | Stickler syndrome, type i, nonsyndromic ocular | Enrichment | COL2A1 | 2.25 |
| 135 | Dystonia 27 | Enrichment | COL6A3 | 2.25 |
| 136 | Muscular dystrophy-dystroglycanopathy , type c, 9 | Enrichment | DAG1 | 2.25 |
| 137 | Loeys-dietz syndrome 5 | Enrichment | TGFB3 | 2.25 |
| 138 | Qualitative or quantitative defects of collagen 6 | Enrichment | COL6A2 | 2.25 |
| 139 | Bent bone dysplasia syndrome 2 | Enrichment | LAMA5 | 2.25 |
| 140 | Vitreoretinopathy with phalangeal epiphyseal dysplasia | Enrichment | COL2A1 | 2.25 |
| 141 | Asphyxia neonatorum | Enrichment | COL1A1 | 2.25 |
| 142 | Bethlem myopathy 1b | Enrichment | COL6A2 | 2.25 |
| 143 | Amelogenesis imperfecta, type ih | Enrichment | ITGB6 | 2.25 |
| 144 | Col4a1-related disorders | Enrichment | COL4A1 | 2.25 |
| 145 | Bethlem myopathy 1c | Enrichment | COL6A3 | 2.25 |
| 146 | Autosomal dominant rhegmatogenous retinal detachment | Enrichment | COL2A1 | 2.25 |
| 147 | Fetomaternal alloimmune thrombocytopenia 3 | Enrichment | ITGA2 | 2.25 |
| 148 | Col4a1 or col4a2-related cerebral small vessel disease | Enrichment | COL4A1 | 2.25 |
| 149 | Multiple epiphyseal dysplasia with myopia and deafness | Enrichment | COL2A1 | 2.25 |
| 150 | Immune dysregulation, neurodevelopmental defects, and colitis | Enrichment | ITGAV | 2.25 |
| 151 | Hypochondrogenesis | Enrichment | COL2A1 | 2.25 |
| 152 | X-linked alport syndrome | Enrichment | COL4A5 | 2.25 |
| 153 | Pneumothorax | Enrichment | COL5A1 | 2.25 |
| 154 | Osteochondritis dissecans | Enrichment | ACAN | 2.25 |
| 155 | Dysspondyloenchondromatosis | Enrichment | COL2A1 | 2.25 |
| 156 | Abdominal aortic aneurysm | Enrichment | COL3A1 | 2.25 |
| 157 | Congenital plasminogen activator inhibitor type 1 deficiency | Enrichment | SERPINE1 | 2.25 |
| 158 | Muscle-eye-brain disease with bilateral multicystic leucodystrophy | Enrichment | DAG1 | 2.25 |
| 159 | Type 2 collagen-related bone disorder | Enrichment | COL2A1 | 2.25 |
| 160 | Lama5-related multisystemic syndrome | Enrichment | LAMA5 | 2.25 |
| 161 | Short stature-advanced bone age-early-onset osteoarthritis syndrome | Enrichment | ACAN | 2.25 |
| 162 | Laminin subunit alpha 2-related muscular dystrophy | Enrichment | LAMA2 | 2.25 |
| 163 | Blood group system, landsteiner-wiener | Enrichment | ICAM4 | 2.21 |
| 164 | Ectopia lentis 1, isolated, autosomal dominant | Enrichment | FBN1 | 2.21 |
| 165 | Epidermolysis bullosa dystrophica, pretibial | Enrichment | COL7A1 | 2.21 |
| 166 | Epidermolysis bullosa dystrophica, autosomal dominant | Enrichment | COL7A1 | 2.21 |
| 167 | Epidermolysis bullosa dystrophica, autosomal recessive | Enrichment | COL7A1 | 2.21 |
| 168 | Von willebrand disease, type 1 | Enrichment | VWF | 2.21 |
| 169 | Systemic lupus erythematosus 6 | Enrichment | ITGAM | 2.21 |
| 170 | Nail disorder, nonsyndromic congenital, 8 | Enrichment | COL7A1 | 2.21 |
| 171 | Corneal dystrophy, posterior polymorphous, 2 | Enrichment | COL8A2 | 2.21 |
| 172 | Transient bullous dermolysis of the newborn | Enrichment | COL7A1 | 2.21 |
| 173 | Corneal dystrophy, fuchs endothelial, 1 | Enrichment | COL8A2 | 2.21 |
| 174 | Epidermolysis bullosa with congenital localized absence of skin and deformity of nails | Enrichment | COL7A1 | 2.21 |
| 175 | Von willebrand disease, type 2 | Enrichment | VWF | 2.21 |
| 176 | Weill-marchesani syndrome 2 | Enrichment | FBN1 | 2.21 |
| 177 | Geleophysic dysplasia 2 | Enrichment | FBN1 | 2.21 |
| 178 | Protrusio acetabuli | Enrichment | FBN1 | 2.21 |
| 179 | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Enrichment | JAM2 | 2.21 |
| 180 | Myasthenic syndrome, congenital, 19 | Enrichment | COL13A1 | 2.21 |
| 181 | Von willebrand disease, type 3 | Enrichment | VWF | 2.21 |
| 182 | Lymphoplasmacytic lymphoma | Enrichment | FBN1 | 2.21 |
| 183 | Epidermolysis bullosa pruriginosa | Enrichment | COL7A1 | 2.21 |
| 184 | Thyroid gland disease | Enrichment | COL7A1 | 2.21 |
| 185 | Hemorrhagic destruction of the brain, subependymal calcification, and cataracts | Enrichment | JAM3 | 2.21 |
| 186 | Von willebrand's disease | Enrichment | VWF | 2.21 |
| 187 | Recessive dystrophic epidermolysis bullosa-generalized other | Enrichment | COL7A1 | 2.21 |
| 188 | Tufted angioma of skin | Enrichment | KDR | 2.21 |
| 189 | Congenital fibrinogen deficiency | Enrichment | FGG | 2.21 |
| 190 | Localized dystrophic epidermolysis bullosa, acral form | Enrichment | COL7A1 | 2.21 |
| 191 | Neonatal marfan syndrome | Enrichment | FBN1 | 2.21 |
| 192 | Recessive dystrophic epidermolysis bullosa inversa | Enrichment | COL7A1 | 2.21 |
| 193 | Porencephaly-microcephaly-bilateral congenital cataract syndrome | Enrichment | JAM3 | 2.21 |
| 194 | Generalized dominant dystrophic epidermolysis bullosa | Enrichment | COL7A1 | 2.21 |
| 195 | Brittle bone disorder | Enrichment | COL1A1, COL1A2 | 2.14 |
| 196 | Scoliosis | Enrichment | COL2A1, FBN1 | 2.02 |
| 197 | Ehlers-danlos syndrome, vascular type | Enrichment | COL3A1 | 1.95 |
| 198 | Cerebral amyloid angiopathy, cst3-related | Enrichment | APP | 1.95 |
| 199 | Wagner vitreoretinopathy | Enrichment | VCAN | 1.95 |
| 200 | Camurati-engelmann disease 1 | Enrichment | TGFB1 | 1.95 |
| 201 | Epidermolysis bullosa, junctional 2c, laryngoonychocutaneous | Enrichment | LAMA3 | 1.95 |
| 202 | Bruck syndrome 1 | Enrichment | COL1A2 | 1.95 |
| 203 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | Enrichment | COL2A1 | 1.95 |
| 204 | Spondyloepimetaphyseal dysplasia, x-linked | Enrichment | BGN | 1.95 |
| 205 | Myasthenic syndrome, congenital, 5 | Enrichment | LAMB2 | 1.95 |
| 206 | Dermatofibrosarcoma protuberans | Enrichment | COL1A1 | 1.95 |
| 207 | Corneal dystrophy, congenital stromal | Enrichment | DCN | 1.95 |
| 208 | Legg-calve-perthes disease | Enrichment | COL2A1 | 1.95 |
| 209 | Lissencephaly 1 | Enrichment | LAMB1 | 1.95 |
| 210 | Specific language impairment 5 | Enrichment | COL4A4 | 1.95 |
| 211 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | Enrichment | COL2A1 | 1.95 |
| 212 | Pierson syndrome | Enrichment | LAMB2 | 1.95 |
| 213 | Sclerosteosis 2 | Enrichment | LRP4 | 1.95 |
| 214 | Schwartz-jampel syndrome, type 1 | Enrichment | HSPG2 | 1.95 |
| 215 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | Enrichment | COL4A2 | 1.95 |
| 216 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 1 | Enrichment | COL1A1 | 1.95 |
| 217 | Fibromuscular dysplasia, multifocal | Enrichment | COL5A1 | 1.95 |
| 218 | Epidermolysis bullosa, junctional 2a, intermediate | Enrichment | LAMA3 | 1.95 |
| 219 | Polymicrogyria with or without vascular-type ehlers-danlos syndrome | Enrichment | COL3A1 | 1.95 |
| 220 | Inflammatory bowel disease, immunodeficiency, and encephalopathy | Enrichment | TGFB1 | 1.95 |
| 221 | Nephrotic syndrome, type 5, with or without ocular abnormalities | Enrichment | LAMB2 | 1.95 |
| 222 | Autosomal recessive hypophosphatemic rickets | Enrichment | DMP1 | 1.95 |
| 223 | Sclerosteosis | Enrichment | LRP4 | 1.95 |
| 224 | Osteogenesis imperfecta, type xvii | Enrichment | SPARC | 1.95 |
| 225 | Camurati-engelmann disease | Enrichment | TGFB1 | 1.95 |
| 226 | Glomerulonephritis | Enrichment | COL4A4 | 1.95 |
| 227 | Stickler syndrome, type ii | Enrichment | COL1A1 | 1.95 |
| 228 | Familial avascular necrosis of the femoral head | Enrichment | COL2A1 | 1.95 |
| 229 | Myasthenic syndrome, congenital, 17 | Enrichment | LRP4 | 1.95 |
| 230 | Degenerative disc disease | Enrichment | ASPN | 1.95 |
| 231 | Epidermolysis bullosa, junctional 2b, severe | Enrichment | LAMA3 | 1.95 |
| 232 | Wagner disease | Enrichment | VCAN | 1.95 |
| 233 | Acromicric dysplasia | Enrichment | FBN1 | 1.91 |
| 234 | Leukocyte adhesion deficiency, type i | Enrichment | ITGB2 | 1.91 |
| 235 | Metaphyseal chondrodysplasia, schmid type | Enrichment | COL10A1 | 1.91 |
| 236 | Stiff skin syndrome | Enrichment | FBN1 | 1.91 |
| 237 | Leukocyte adhesion deficiency, type iii | Enrichment | ITGB2 | 1.91 |
| 238 | Beaulieu-boycott-innes syndrome | Enrichment | FBN1 | 1.91 |
| 239 | Angioma, tufted | Enrichment | KDR | 1.91 |
| 240 | Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome | Enrichment | ITGA3 | 1.91 |
| 241 | Recessive dystrophic epidermolysis bullosa | Enrichment | COL7A1 | 1.91 |
| 242 | Marfanoid-progeroid-lipodystrophy syndrome | Enrichment | FBN1 | 1.91 |
| 243 | Glaucoma, primary closed-angle | Enrichment | COL18A1 | 1.91 |
| 244 | Epidermolysis bullosa dystrophica | Enrichment | COL7A1 | 1.91 |
| 245 | Lens subluxation | Enrichment | FBN1 | 1.91 |
| 246 | Stargardt disease 1 | Enrichment | COL18A1, COL2A1 | 1.83 |
| 247 | Genetic steroid-resistant nephrotic syndrome | Enrichment | COL4A3, LAMA5 | 1.81 |
| 248 | Hyper-ige syndrome 1, autosomal dominant, with recurrent infections | Enrichment | ITGB3 | 1.78 |
| 249 | Retinal arteries, tortuosity of | Enrichment | COL4A1 | 1.78 |
| 250 | Spondyloepiphyseal dysplasia congenita | Enrichment | COL2A1 | 1.78 |
| 251 | Dyssegmental dysplasia, silverman-handmaker type | Enrichment | HSPG2 | 1.78 |
| 252 | Telecanthus | Enrichment | COL5A2 | 1.78 |
| 253 | Glomerulopathy with fibronectin deposits 2 | Enrichment | FN1 | 1.78 |
| 254 | Ehlers-danlos syndrome, classic-like, 1 | Enrichment | TNXB | 1.78 |
| 255 | Muscular dystrophy, congenital merosin-deficient, 1a | Enrichment | LAMA2 | 1.78 |
| 256 | Caffey disease | Enrichment | COL1A1 | 1.78 |
| 257 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | Enrichment | ITGA7 | 1.78 |
| 258 | Brain small vessel disease 2 | Enrichment | COL4A2 | 1.78 |
| 259 | Cenani-lenz syndactyly syndrome | Enrichment | LRP4 | 1.78 |
| 260 | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | Enrichment | COL4A1 | 1.78 |
| 261 | Vesicoureteral reflux 8 | Enrichment | TNXB | 1.78 |
| 262 | Pilarowski-bjornsson syndrome | Enrichment | COL4A3 | 1.78 |
| 263 | Alport syndrome 3b, autosomal recessive | Enrichment | COL4A3 | 1.78 |
| 264 | Bronchopulmonary dysplasia | Enrichment | MUSK | 1.78 |
| 265 | Poretti-boltshauser syndrome | Enrichment | LAMA1 | 1.78 |
| 266 | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps | Enrichment | COL4A1 | 1.78 |
| 267 | Hematuria, benign familial, 2 | Enrichment | COL4A3 | 1.78 |
| 268 | Familial vesicoureteral reflux | Enrichment | TNXB | 1.78 |
| 269 | Bleeding disorder, platelet-type, 24 | Enrichment | ITGB3 | 1.78 |
| 270 | Alopecia - intellectual disability syndrome | Enrichment | ITGB6 | 1.78 |
| 271 | Lama2-related muscular dystrophy | Enrichment | LAMA2 | 1.78 |
| 272 | Contractural arachnodactyly, congenital | Enrichment | FBN1 | 1.73 |
| 273 | Achondroplasia | Enrichment | FBN1 | 1.73 |
| 274 | Nail disorder, nonsyndromic congenital, 4 | Enrichment | COL7A1 | 1.73 |
| 275 | Periventricular nodular heterotopia 1 | Enrichment | VWF | 1.73 |
| 276 | Epidermolysis bullosa, junctional 6, with pyloric atresia | Enrichment | ITGA6 | 1.73 |
| 277 | Weill-marchesani syndrome 1 | Enrichment | FBN1 | 1.73 |
| 278 | Isolated ectopia lentis | Enrichment | FBN1 | 1.73 |
| 279 | Geleophysic dysplasia | Enrichment | FBN1 | 1.73 |
| 280 | Hyperpigmentation of the skin | Enrichment | COL7A1 | 1.73 |
| 281 | Cerebral palsy | Enrichment | COL4A1, COL4A2 | 1.70 |
| 282 | Sensorineural hearing loss | Enrichment | COL9A1 | 1.68 |
| 283 | Amelogenesis imperfecta, type iiia | Enrichment | ITGB6 | 1.65 |
| 284 | Phenylketonuria | Enrichment | COL1A1 | 1.65 |
| 285 | Schizencephaly | Enrichment | COL4A1 | 1.65 |
| 286 | Dentin dysplasia, type i | Enrichment | DSPP | 1.65 |
| 287 | Diabetes insipidus | Enrichment | MATN4 | 1.65 |
| 288 | Rare x-linked non-syndromic sensorineural deafness type dfn | Enrichment | COL4A6 | 1.65 |
| 289 | Pseudomyogenic hemangioendothelioma | Enrichment | SERPINE1 | 1.65 |
| 290 | Systemic lupus erythematosus | Enrichment | ITGAM, SPP1 | 1.62 |
| 291 | Retinitis pigmentosa 26 | Enrichment | ITGA4 | 1.61 |
| 292 | Weill-marchesani syndrome | Enrichment | FBN1 | 1.61 |
| 293 | Aortic aneurysm | Enrichment | FBN1 | 1.61 |
| 294 | Epidermolytic hyperkeratosis | Enrichment | COL7A1 | 1.61 |
| 295 | Knobloch syndrome | Enrichment | COL18A1 | 1.61 |
| 296 | Cerebral malaria | Enrichment | ICAM1 | 1.61 |
| 297 | Mitral valve insufficiency | Enrichment | FBN1 | 1.61 |
| 298 | Pediatric systemic lupus erythematosus | Enrichment | SPP1 | 1.61 |
| 299 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | TGFB3 | 1.56 |
| 300 | Myasthenic syndrome, congenital, 8 | Enrichment | AGRN | 1.56 |
| 301 | Glanzmann thrombasthenia 2 | Enrichment | ITGB3 | 1.56 |
| 302 | Muscular dystrophy, limb-girdle, autosomal recessive 23 | Enrichment | LAMA2 | 1.56 |
| 303 | Holoprosencephaly | Enrichment | MATN4 | 1.56 |
| 304 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | TGFB3 | 1.56 |
| 305 | Familial cerebral saccular aneurysm | Enrichment | COL3A1 | 1.56 |
| 306 | Polycystic liver disease 1 with or without kidney cysts | Enrichment | FBN1 | 1.51 |
| 307 | Epidermolytic hyperkeratosis 1 | Enrichment | COL7A1 | 1.51 |
| 308 | Amyloidosis, hereditary systemic 2 | Enrichment | FGA | 1.51 |
| 309 | Arthrogryposis, renal dysfunction, and cholestasis 1 | Enrichment | FBN1 | 1.51 |
| 310 | Knobloch syndrome 1 | Enrichment | COL18A1 | 1.51 |
| 311 | Goldberg-shprintzen syndrome | Enrichment | FBN1 | 1.51 |
| 312 | Fuchs' endothelial dystrophy | Enrichment | COL8A2 | 1.51 |
| 313 | Polycystic liver disease 1 | Enrichment | FBN1 | 1.51 |
| 314 | Atrial septal defect 1 | Enrichment | TGFB2 | 1.48 |
| 315 | Spondyloepiphyseal dysplasia with congenital joint dislocations | Enrichment | ACAN | 1.48 |
| 316 | Developmental dysplasia of the hip 1 | Enrichment | COL2A1 | 1.48 |
| 317 | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | Enrichment | TNXB | 1.48 |
| 318 | Epidermolysis bullosa, junctional 1a, intermediate | Enrichment | LAMA3 | 1.48 |
| 319 | Epidermolysis bullosa, junctional 1b, severe | Enrichment | LAMA3 | 1.48 |
| 320 | Holoprosencephaly 1 | Enrichment | MATN4 | 1.48 |
| 321 | Anterior segment dysgenesis 5 | Enrichment | COL4A1 | 1.48 |
| 322 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | TGFB1 | 1.48 |
| 323 | Junctional epidermolysis bullosa non-herlitz type | Enrichment | LAMA3 | 1.48 |
| 324 | Pain disorder | Enrichment | COL5A1 | 1.48 |
| 325 | Il10-related early-onset inflammatory bowel disease | Enrichment | TGFB1 | 1.48 |
| 326 | 21-hydroxylase-deficient congenital adrenal hyperplasia | Enrichment | TNXB | 1.48 |
| 327 | Corneal dystrophy, posterior polymorphous, 1 | Enrichment | COL8A2 | 1.44 |
| 328 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | ITGA6 | 1.44 |
| 329 | Hemangioma, capillary infantile | Enrichment | KDR | 1.44 |
| 330 | Multiple enchondromatosis, maffucci type | Enrichment | COL2A1 | 1.41 |
| 331 | Alzheimer's disease 1 | Enrichment | APP | 1.41 |
| 332 | Early-onset autosomal dominant alzheimer disease | Enrichment | APP | 1.41 |
| 333 | Hypophosphatemic rickets | Enrichment | DMP1 | 1.41 |
| 334 | Nevus, epidermal | Enrichment | COL7A1 | 1.37 |
| 335 | Thrombophilia due to thrombin defect | Enrichment | FGA | 1.37 |
| 336 | Brugada syndrome 1 | Enrichment | FBN1 | 1.37 |
| 337 | Gastroesophageal reflux | Enrichment | COL5A1 | 1.36 |
| 338 | Renal hypodysplasia/aplasia 1 | Enrichment | ITGA8 | 1.36 |
| 339 | Congenital muscular dystrophy | Enrichment | LAMA2 | 1.36 |
| 340 | Basal ganglia calcification, idiopathic, 1 | Enrichment | JAM2 | 1.31 |
| 341 | Junctional epidermolysis bullosa | Enrichment | LAMA3 | 1.31 |
| 342 | Renal agenesis, bilateral | Enrichment | ITGA8 | 1.31 |
| 343 | Primary ovarian insufficiency | Enrichment | KDR, THBS1 | 1.29 |
| 344 | Peters-plus syndrome | Enrichment | COL4A1 | 1.26 |
| 345 | Amelogenesis imperfecta, type ie | Enrichment | ITGB6 | 1.26 |
| 346 | Myasthenic syndrome, congenital, 4c, associated with acetylcholine receptor deficiency | Enrichment | MUSK | 1.26 |
| 347 | Stroke, ischemic | Enrichment | FBN1 | 1.22 |
| 348 | Melanoma | Enrichment | FBN1 | 1.22 |
| 349 | Cutis laxa | Enrichment | COL5A1 | 1.19 |
| 350 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | TGFB3 | 1.19 |
| 351 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | TGFB3 | 1.19 |
| 352 | Pectus excavatum | Enrichment | FBN1 | 1.18 |
| 353 | Ichthyosis | Enrichment | COL7A1 | 1.18 |
| 354 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | COL5A1 | 1.15 |
| 355 | Neural tube defects | Enrichment | ITGB1 | 1.15 |
| 356 | Alzheimer's disease | Enrichment | APP | 1.15 |
| 357 | Clubfoot | Enrichment | COL5A1 | 1.15 |
| 358 | Chromosome 1p36 deletion syndrome | Enrichment | HSPG2 | 1.15 |
| 359 | Nk-cell enteropathy | Enrichment | PTPRS | 1.15 |
| 360 | Lipoid congenital adrenal hyperplasia | Enrichment | TNXB | 1.12 |
| 361 | Congenital myasthenic syndrome | Enrichment | AGRN | 1.12 |
| 362 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | TGFB3 | 1.12 |
| 363 | Diaphragmatic hernia, congenital | Enrichment | FBN1 | 1.11 |
| 364 | Hereditary retinal dystrophy | Enrichment | COL2A1, COL9A1, LAMA1, VCAN | 1.10 |
| 365 | Fundus dystrophy | Enrichment | COL2A1, COL9A1, LAMA1, VCAN | 1.10 |
| 366 | Congenital myopathy 4a, autosomal dominant | Enrichment | ITGA7 | 1.09 |
| 367 | Corpus callosum, agenesis of | Enrichment | COL4A1 | 1.09 |
| 368 | Anterior segment dysgenesis | Enrichment | COL4A1 | 1.09 |
| 369 | Atypical hemolytic-uremic syndrome | Enrichment | COL4A5 | 1.09 |
| 370 | Isolated corpus callosum agenesis | Enrichment | COL4A1 | 1.09 |
| 371 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | COL4A1 | 1.09 |
| 372 | Alzheimer disease, familial, 1 | Enrichment | APP | 1.04 |
| 373 | Perrault syndrome 1 | Enrichment | FBN1 | 1.02 |
| 374 | Heart, malformation of | Enrichment | COL2A1 | 1.02 |
| 375 | Polycystic kidney disease | Enrichment | COL4A4 | 1.02 |
| 376 | Myocardial infarction | Enrichment | ITGB3 | 0.93 |
| 377 | Hepatoblastoma | Enrichment | COL7A1 | 0.91 |
| 378 | Muscular dystrophy | Enrichment | COL6A2 | 0.90 |
| 379 | Skin disease | Enrichment | COL7A1 | 0.89 |
| 380 | Malaria | Enrichment | ICAM1 | 0.88 |
| 381 | Tetralogy of fallot | Enrichment | KDR | 0.83 |
| 382 | Severe covid-19 | Enrichment | ITGAV | 0.82 |
| 383 | Microcephaly | Enrichment | COL4A1, MATN4 | 0.82 |
| 384 | Cystic fibrosis | Enrichment | TGFB1 | 0.78 |
| 385 | Cakut | Enrichment | COL4A1 | 0.76 |
| 386 | Fetal akinesia deformation sequence 1 | Enrichment | MUSK | 0.73 |
| 387 | Charcot-marie-tooth disease | Enrichment | LAMA2 | 0.69 |
| 388 | Hypertelorism | Enrichment | COL1A1 | 0.60 |
| 389 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | TNC | 0.60 |
| 390 | Familial isolated dilated cardiomyopathy | Enrichment | LAMA4 | 0.59 |
| 391 | Cone-rod dystrophy 2 | Enrichment | ITGA4 | 0.46 |
| 392 | Rare genetic deafness | Enrichment | COL4A5 | 0.44 |
| 393 | Dilated cardiomyopathy | Enrichment | LAMA2 | 0.44 |
| 394 | Retinitis pigmentosa | Enrichment | COL18A1 | 0.13 |